Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes
about
Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer.Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis.DNA vaccines for the treatment of prostate cancer.Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.Cellular immunotherapy strategies for Ewing sarcoma.mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer.Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens.The STEAP1(262-270) peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic mice--A new approach to immunotherapy against prostate carcinoma.IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killingTumor-associated antigens for specific immunotherapy of prostate cancerAntigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells.Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.
P2860
Q34590434-10674F56-D1E2-4679-ACA6-F9A4C89BC291Q35196739-660DF6CC-9029-424B-91A8-A09098CE9644Q35560066-92212A4B-8471-4D97-8DFC-C8AFDE964EE7Q36471831-DC8AEE8E-D2D0-44D8-BC9F-1D727E84B097Q36847275-ABAA7C0D-993F-4E53-8B33-FEF32ACF0914Q37771942-FCFCC033-8993-4E74-856C-D7FD64060D4CQ38000961-155B7E1C-2811-4E52-9627-B1E9CEDE98CCQ38217594-0BAD7233-17AE-4E06-B9BF-4E2154682390Q38284699-6B463E60-DB84-4810-85A0-F341B80547F7Q39472050-D52EA410-975F-41B0-A69C-892B82778014Q40160897-504AF5C2-0B49-4A0D-818C-B996B7AB7A85Q40987686-DB9AB6AF-5812-4F64-9150-FE9B48575C84Q41977894-7D1608EA-EC70-4E98-ACCE-5985272422B7Q42003336-2189D89F-5E55-4D16-8736-438AFB4E5A69Q55040339-BED80C1A-2040-49C9-A7F2-D4EC8BC7DF3A
P2860
Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@ast
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@en
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@nl
type
label
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@ast
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@en
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@nl
prefLabel
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@ast
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@en
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@nl
P2093
P2860
P3181
P1476
Recognition of six-transmembra ...... nduced cytotoxic T lymphocytes
@en
P2093
David A Rodeberg
Esteban Celis
Rebecca A Nuss
Sherine F Elsawa
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-04-2235
P407
P577
2005-06-15T00:00:00Z